Data Strategy Consulting and AI Readiness for Life Sciences
A smart data strategy is essential for innovation, compliance, and performance. ProPharma's data strategy consulting services help life sciences organizations establish the trusted, governed, and discoverable data foundation required for AI, advanced analytics, and digital transformation.
Why Do You Need a Data Strategy?
A robust data strategy aligns data with business objectives, establishes effective governance and standards, and ensures information is trustworthy, accessible and fit for purpose. It provides the foundation for regulatory compliance, operational efficiency, digital transformation and AI adoption
Data Strategy Benefits
Innovation and Efficiency
Optimized data collection, management and accessibility help organizations streamline operations, reduce inefficiencies and accelerate innovation across research,...
Read MoreInnovation and Efficiency
Optimized data collection, management and accessibility help organizations streamline operations, reduce inefficiencies and accelerate innovation across research, development, manufacturing and clinical functions.
Read LessRegulatory Compliance and Data Integrity
Life sciences organizations operate in highly regulated environments. Effective data governance, standards and stewardship support data integrity,...
Read MoreRegulatory Compliance and Data Integrity
Life sciences organizations operate in highly regulated environments. Effective data governance, standards and stewardship support data integrity, traceability and regulatory compliance.
Read LessBetter Decision-Making
Accessible, trustworthy and well-governed data enables faster, more informed decisions, helping organizations improve research outcomes, operational performance and patient...
Read MoreBetter Decision-Making
Accessible, trustworthy and well-governed data enables faster, more informed decisions, helping organizations improve research outcomes, operational performance and patient outcomes.
Read LessCompetitive Advantage
Organizations that effectively manage and leverage their data are better positioned to identify opportunities, accelerate digital transformation and realize value from...
Read MoreCompetitive Advantage
Organizations that effectively manage and leverage their data are better positioned to identify opportunities, accelerate digital transformation and realize value from analytics and AI initiatives.
Read LessData Strategy for AI and AI Readiness
Many organizations are exploring AI but struggle with fragmented data, inconsistent definitions, poor discoverability or limited governance. A successful AI data...
Read MoreData Strategy for AI and AI Readiness
Many organizations are exploring AI but struggle with fragmented data, inconsistent definitions, poor discoverability or limited governance. A successful AI data strategy depends on trusted, accessible and well-managed information.
Our consultants help organizations perform an AI readiness assessment and establish the data foundations required to support advanced analytics, automation and AI adoption. This includes governance, data quality, metadata management, information architecture and change management.
Read LessFAIR Data, Metadata and Ontologies
Making data Findable, Accessible, Interoperable and Reusable (FAIR) is increasingly important for modern life sciences organizations. We help clients improve the...
Read MoreFAIR Data, Metadata and Ontologies
Making data Findable, Accessible, Interoperable and Reusable (FAIR) is increasingly important for modern life sciences organizations. We help clients improve the discoverability and usability of their data through metadata management, controlled vocabularies, ontologies and data standards.
Our experience includes supporting industry initiatives and consortia, enabling organizations to create sustainable data foundations that support collaboration, regulatory requirements and future AI applications.
Read LessHow Can We Help With Your Data Strategy?
We support data strategy initiatives across R&D, clinical, regulatory, manufacturing and quality domains, including pharmaceutical, biotechnology and medical device settings.
Our Data Strategy Consulting service helps life sciences organizations establish the foundations required to manage, govern and derive value from their data. Combining deep scientific expertise with data and technology consulting experience, we help clients define practical strategies that align with business objectives and support future digital transformation initiatives.
We also help organizations design and govern data products that transform data into reusable business assets. Data products support reporting, analytics and AI use cases by making trusted, high-value information easier to access, understand and consume across the organization.
Our Data Strategy Process
Start with a Digital Blueprint Assessment
Many organizations begin with a Digital Blueprint assessment to understand how data flows across the business and identify inefficiencies, silos and barriers to reuse. By examining the entire data lifecycle—from capture and creation through management, integration and reuse—we develop a blueprint for digital continuity that connects people, processes, data and technology. This helps organizations establish FAIR data principles at the source, improve data quality and discoverability, and make smarter investments in digital transformation and AI that are aligned to clear business outcomes.
Data Maturity Assessment
We assess your current data maturity against industry-wide definitions and use the findings to develop a practical data strategy roadmap. This helps prioritize the actions required to improve data management, governance and readiness for analytics and AI.
Data Strategy, Governance, and Standards
By establishing effective data strategy, governance and standards, organizations can improve trust in their data, reduce duplication and create a strong foundation for analytics, automation and AI. Clear ownership, policies and standards support better decision-making while ensuring alignment with business goals and regulatory requirements.
Use Cases
Use cases are essential considerations in defining the practical application of data, ensuring that insights align with your business objectives and drive measurable outcomes. By working with you to identify and implement clear use cases, your organization can prioritize data initiatives, optimize resource allocation, and enhance decision-making effectiveness.
Prioritised use cases help organisations focus investment on the right solutions for the right business problems. By clearly defining the desired outcomes, understanding the data required to support them and anticipating the process, behavioural and governance changes needed for adoption, organisations can maximise the value delivered by digital transformation, analytics and AI initiatives.
No matter where you are in your data strategy journey, ProPharma can help assess your current capabilities, identify opportunities for improvement and develop a practical roadmap for measurable business value.
No matter where you are in your data strategy journey, ProPharma can help assess your current capabilities, identify opportunities for improvement and develop a practical roadmap for measurable business value.
Data Strategy Thought Leadership
Digital Transformation First: Why AI Investment Depends on Strategy, Data, and Operational Readiness
Our recent LinkedIn poll asked a simple question: What is the first step in a digital transformation journey? The response was decisive. Seventy percent of respondents identified strategy definition...
Digital Transformation in Life Sciences: The Importance of Data Strategy
What is Digital Transformation? While there are many different definitions of digital transformation in life sciences, the core concepts they all have in common are digital technology and creating...
Webinar Replay: The Path to Clarity – Unlocking the Power of Data Standards for Digital Transformation
In today’s data-driven R&D landscape, organizations face a deluge of complex, siloed, and incompatible data that hinders innovation and slows progress.
This webinar explores how implementing robust data standards and governance frameworks can transform fragmented information into actionable intelligence. Led by experts from ProPharma and CSL
Expert Data Strategy Consulting Services
Our data strategy consulting services help life sciences organizations establish the trusted data foundations required for innovation, compliance, digital transformation and AI adoption.
Our Data Strategy Consultants & Experts
-
Helen Lucke
Data Strategy Lead
View Bio
-
Joost Van Kempen
Business Consultant
View Bio
-
Pete Bament
Business Consultant
View Bio
-
Michael Burns
Business Consultant
View Bio
-
Kirsty Payne
Business Consultant
View Bio
-
Dana Vanderwall
Vice President, Digital Transformation
View Bio
Helen Lucke
Helen Lucke is a Data Strategy Lead within ProPharma's Digital Transformation practice, specializing in data strategy, data governance, and scientific informatics for life sciences organizations. She helps clients improve the quality, management, and use of data to support regulatory compliance, operational efficiency, and digital transformation initiatives.
Joost Van Kempen
Joost is an experienced leader in providing strategies that help organizations improve their science through better utilization of technology and data. He has been instrumental in setting up and implementing data and digitization strategies in a diverse set of international settings across both industry and academia.
Pete Bament
Pete is an experienced data leader with over 22 years of experience working across the pharmaceutical product lifecycle, from R&D to manufacturing. He has developed a broad knowledge base through personal experience and by working closely with partners in Quality, Technical, Production, Logistics, Finance, Clinical, Data, and IT functions.
Michael Burns
Michael Burns has over 20 years of experience providing technical and business solutions to the pharmaceutical and biopharma R&D sector. He has experience in the Information Technology domain supporting, delivering, and managing IT solutions. He has also worked extensively as a consultant, delivering scientific software solutions, including Electronic Laboratory Notebooks, Data Management, Bioinformatics, and streamlining scientific workflows.
Mike has a proven track record of fostering understanding and collaboration across diverse groups of stakeholders.
Kirsty Payne
Dana Vanderwall
Dana Vanderwall is an innovative leader in scientific solutions for drug discovery and digital transformation, with over 25 years of experience in pharmaceutical and biopharma R&D. He has experience in biochemistry, structural biology, computational chemistry, cheminformatics, IT, and data strategy in pharmaceutical R&D, as well as product management for enterprise informatics software. Dana has extensive experience providing an interface between IT and senior R&D leadership, responsible for the planning and delivery of informatics platforms, services, and tools in alignment with scientific goals and strategy. He has also led the strategy development and implementation of an R&D-wide metadata layer.
News & Insights
October 21, 2026
From Defensible to Predictive: How High-Functioning MLR Teams Are Evolving Their...
Recent FDA enforcement activity is changing how MLR teams assess promotional risk. Learn why organizations are moving from defensible claims to predictive, enforcement-informed risk assessment.
October 19, 2026
AI-Readiness 101: AI Success Starts with Understanding Your Data
Unlock AI success by understanding your data. Learn the foundations of AI readiness and how to build trust in your data for reliable insights.
July 8, 2026
ProPharma Advances Technology Enablement Strategy with AI-Assisted Capability fo...
ProPharma unveils an AI-assisted capability to enhance ANDA submission development, improving efficiency and maintaining regulatory excellence for clients.
June 18, 2026
ProPharma Welcomes Kevin van Dooren to Strengthen Integrated EU Regulatory and H...
ProPharma welcomes Kevin van Dooren as Vice President, HEOR and Market Access, strengthening integrated EU regulatory, HTA, reimbursement, and market access capabilities for life sciences companies.
January 31, 2025
ProPharma Recognized for AI Excellence at ECCCSA
ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.
October 9, 2024
ProPharma Receives 2024 CPHI Regulatory and Compliance Award
ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.
October 20, 2026
Accelerating Clinical Trial Activation Across Latin America
Launching clinical trials across multiple countries requires navigating varying regulatory requirements, site contracts, translations, import/export processes, and site engagement activities, all...
September 18, 2026
Flexible Resourcing Without Limits: Scaling Capabilities Across the Development ...
Development complexity doesn’t increase in a straight line. As programs progress from discovery through Phase III, submission, and post-approval, demands for medical writing, biometrics, clinical...
August 3, 2026
Achieving Continuous Audit Readiness Across a Global Medical Information Program
Maintaining continuous audit readiness across a global Medical Information operation requires more than periodic audit preparation. Organizations operating across multiple countries and affiliates...
December 2, 2026
Beyond the Buzz: Leveraging Community Management to Enhance Medical Information
Patients, caregivers, and healthcare professionals are increasingly turning to digital channels to seek information, share experiences, and discuss treatments. Join this webinar to explore how...
November 12, 2026
Empowering Sites, Engaging Patients: Strategies to Improve Clinical Trial Performance
Sites are being asked to do more than ever before while balancing increasing trial complexity, patient expectations, and operational demands. Join this webinar to explore how flexible, integrated...
News & Insights
September 18, 2026
Flexible Resourcing Without Limits: Scaling Capabilities Across the Development ...
Development complexity doesn’t increase in a straight line. As programs progress from discovery through Phase III, submission, and post-approval, demands for medical writing, biometrics, clinical...
August 3, 2026
Achieving Continuous Audit Readiness Across a Global Medical Information Program
Maintaining continuous audit readiness across a global Medical Information operation requires more than periodic audit preparation. Organizations operating across multiple countries and affiliates...
November 12, 2026
Empowering Sites, Engaging Patients: Strategies to Improve Clinical Trial Performance
Sites are being asked to do more than ever before while balancing increasing trial complexity, patient expectations, and operational demands. Join this webinar to explore how flexible, integrated...